Relapse after first allogeneic stem cell transplant for hematologic malignancies in children: should we do it again?
Pediatr Transplant., Nov;16(7):695-6 (2012)
Immune markers of disease severity and treatment response in pediatric acquired aplastic anemia.
Pediatr Blood Cancer., Jul (2012)
Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised adolescents and healthy adults.
Antimicrob. Agents Chemother., Dec;55(12):5780-9 (2011)
Outcome of myeloablative conditioning and unrelated donor hematopoietic cell transplantation for childhood acute lymphoblastic leukemia in third remission.
Biol. Blood Marrow Transplant., Dec;17(12):1833-40 (2011)
Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies.
Biol. Blood Marrow Transplant., Mar;17(3):341-50 (2011)
Evaluation of pentostatin in corticosteroid-refractory chronic graft-versus-host disease in children: a Pediatric Blood and Marrow Transplant Consortium study.
Blood., Nov;114(20):4354-60 (2009)
Pretargeting CD45 enhances the selective delivery of radiation to hematolymphoid tissues in nonhuman primates.
Blood., Aug;114(6):1226-35 (2009)
The evolving spectrum of 'non-classical' Diamond-Blackfan anaemia--a case of eADA positive pancytopenia in a young adult.
Br. J. Haematol., May;145(3):428-30 (2009)
Extracorporeal adsorption therapy: a method to improve targeted radiation delivered by radiometal-labeled monoclonal antibodies.
Cancer Biother. Radiopharm., Apr;23(2):181-91 (2008)
A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study.
Blood., Dec;110(13):4584-7 (2007)
Biodistribution of yttrium-90-labeled anti-CD45 antibody in a nonhuman primate model.
Clin. Cancer Res., Jan;11(2 Pt 1):787-94 (2005)